Wharton S Jelly Stem Cell Therapy

Umbilical cord wharton s jelly as a potential source for stem cells.

Wharton s jelly stem cell therapy.

Indeed wharton s jelly is among the simplest of human connective tissues and provides an apparently more homogeneous harvested cell population than other mesenchymal tissue sources. Therapeutic potential of wharton s jelly mesenchymal stem cells for diabetes. How regenerative medicine using umbilical cord wharton s jelly allograft can help your joint pain. Wharton s jelly is considered immunologically privileged meaning the host s immune system is unable to detect.

Patients who may have been struggling with joint pain and patients with cancers too would finally have therapies that gave better results. Diabetes mellitus dm is a devastating metabolic disease in which insulin secreting β cells in the islets. The use of stem cells in medicine has been at times a controversial therapy but the results of regenerative medicine can be dramatic. Wharton s jelly derived stem cells on the other hand appear to circumvent both of these problems making them valuable for a variety of applications in medicine.

Wharton s jelly stem cells present a more efficient rate of proliferation than stem cells found in the bone marrow. Increasing numbers of both scientists and clinicians are interested in this tissue generally discarded at birth as a source of cells for therapy. Mesenchymal stem cells which are the basis for a number of stem cell therapies and the relevant research may be limited in value when they have been collected from older patients. The advantages of wharton s jelly therapy are twofold.